Mana Ventures — 2024 Investments
4 investments dated 2024 · listed companies and verified rows first · show all
Arda develops therapeutics using single-cell computational biology to target and eliminate pathogenic cells in chronic diseases.
AI & Machine LearningBiotechMedical DevicesAustin, US
Adam Freund(Founder & Chief Executive Officer)Remi-Martin Laberge(Founder and Chief Technology Officer)
BoardVineeta Agarwala(Director)in
Co-investorsage1Andreessen HorowitzStrawberry Creek VenturesAlumni VenturesGaingelsGV (Google Ventures)+3 more
Figure develops general-purpose humanoid robots designed for deployment in workforce and home environments.
AI & Machine LearningHardwareRoboticsSunnyvale, US
Brett Adcock(Executive Officer, Director)inLee Randaccio(Executive Officer)Dana Berlin(Executive Officer)Logan Berkowitz(Executive Officer)Colby Adcock(Director)Peter Welinder(Director)
Co-investorsAUDEO VENTURESAurum Venture PartnersBeyond CapitalBold Capital PartnersBVVCCoatue Management+25 more
Outpace Bio develops engineered protein technologies and cell therapies to treat solid tumors, focusing on protein design and T cell engineering to improve cancer treatment efficacy and safety.
BiotechDeep TechMedical DevicesSeattle, US
Marc Lajoie(Co-founder & Chief Executive Officer)Scott Boyken(Co-founder & Chief Technology Officer)Stanley Riddell(Co-Founder and Scientific Advisor)Aaron Foster(Executive Officer)Charity Scripture(Executive Officer)Eric Soller(Executive Officer)
Co-investorsArtis VenturesRA CapitalAbstract VenturesAtinum Investment Co. Ltd.Civilization Ventures Management, LlcModi Ventures+1 more
Q.bio provides quantitative biology assessments and longitudinal health monitoring for preventive care, offering comprehensive measurable exams at the scale of premium care providers.
AI & Machine LearningBiotechDigital HealthHealthtechSan Carlos, US
Jeffrey Kaditz(Executive Officer, Director, Promoter)Clarissa Shen(Executive Officer)
BoardTerry Doyle(Director)Vijay Pande, Ph.D.(Director)
Co-investorsAndreessen HorowitzBeast VenturesEvolution Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.